(Q90228470)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31547131%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

review article

1 reference

title

Virus-Like Particle Systems for Vaccine Development against Viruses in the Flaviviridae Family (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31547131%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31547131%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

author name string

Shu Hui Wong

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31547131%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

Alagie Jassey

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31547131%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

Wei-Cheng Wang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31547131%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

Ching-Hsuan Liu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31547131%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

Liang-Tzung Lin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31547131%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

publication date

20 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31547131%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31547131%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31547131%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31547131%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

12 April 2020

copyright license

start time

20 September 2019

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Mice immunized with a subviral particle containing the Japanese encephalitis virus prM/M and E proteins are protected from lethal JEV infection

1 reference

12 December 2020

Vaccination of chimpanzees against infection by the hepatitis C virus

1 reference

12 December 2020

Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form

1 reference

12 December 2020

Recombinant subviral particles from tick-borne encephalitis virus are fusogenic and provide a model system for studying flavivirus envelope glycoprotein functions

1 reference

12 December 2020

Particulate vaccine candidate for Japanese encephalitis induces long-lasting virus-specific memory T lymphocytes in mice

1 reference

12 December 2020

Hepatitis C virus structural proteins assemble into viruslike particles in insect cells

1 reference

12 December 2020

Hepatitis C virus-like particles synthesized in insect cells as a potential vaccine candidate

1 reference

12 December 2020

Generation and Characterization of a Mammalian Cell Line Continuously Expressing Japanese Encephalitis Virus Subviral Particles

1 reference

12 December 2020

Hepatitis C virus-like particles induce virus-specific humoral and cellular immune responses in mice

1 reference

12 December 2020

A recombinant particulate antigen of Japanese encephalitis virus produced in stably-transformed cells is an effective noninfectious antigen and subunit immunogen

1 reference

12 December 2020

Prospects for development of a vaccine against the West Nile virus

1 reference

12 December 2020

Enzyme-linked immunosorbent assay using recombinant antigens expressed in mammalian cells for serodiagnosis of tick-borne encephalitis

1 reference

12 December 2020

Stable High-Producer Cell Clone Expressing Virus-Like Particles of the Japanese Encephalitis Virus E Protein for a Second-Generation Subunit Vaccine

1 reference

12 December 2020

Incorporation of Tick-Borne Encephalitis Virus Replicons into Virus-Like Particles by a Packaging Cell Line

1 reference

12 December 2020

THE ABILITY OF AN ATTENUATED ISOLATE OF LANGAT VIRUS TO PROTECT PRIMATES AND MICE AGAINST OTHER MEMBERS OF THE RUSSIAN SPRING-SUMMER VIRUS COMPLEX.

1 reference

12 December 2020

Equine vaccine for West Nile virus

1 reference

12 December 2020

West Nile virus: an overview of its spread in Europe and the Mediterranean basin in contrast to its spread in the Americas

1 reference

12 December 2020

High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection

1 reference

12 December 2020

Induction of sterilizing immunity against West Nile Virus (WNV), by immunization with WNV-like particles produced in insect cells

1 reference

12 December 2020

[Expression of tick-borne encephalitis virus prM-E protein in insect cells and studies on its antigenicity].

1 reference

12 December 2020

Induction of primary human T cell responses against hepatitis C virus-derived antigens NS3 or core by autologous dendritic cells expressing hepatitis C virus antigens: potential for vaccine and immunotherapy

1 reference

12 December 2020

Production and characterization of vaccines based on flaviviruses defective in replication

1 reference

12 December 2020

Yellow fever: a disease that has yet to be conquered

1 reference

12 December 2020

Expression of particulate-form of Japanese encephalitis virus envelope protein in a stably transfected Drosophila cell line

1 reference

12 December 2020

Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees

1 reference

12 December 2020

Characterization of the dengue virus envelope glycoprotein expressed in Pichia pastoris

1 reference

12 December 2020

Production of Pseudoinfectious Yellow Fever Virus with a Two-Component Genome

1 reference

12 December 2020

A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse

1 reference

12 December 2020

Recombinant retrovirus-like particle forming DNA vaccines in prime-boost immunization and their use for hepatitis C virus vaccine development.

1 reference

12 December 2020

Chimeric hepatitis B and C viruses envelope proteins can form subviral particles: implications for the design of new vaccine strategies.

1 reference

12 December 2020

Recombinant dengue virus-like particles from Pichia pastoris: efficient production and immunological properties

1 reference

12 December 2020

Bioinformatics in new generation flavivirus vaccines

1 reference

12 December 2020

Yellow fever: a reemerging threat

1 reference

12 December 2020

A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice

1 reference

12 December 2020

Molecular epidemiology of Powassan virus in North America

1 reference

12 December 2020

Immunogenicity and efficacy of two types of West Nile virus-like particles different in size and maturation as a second-generation vaccine candidate

1 reference

12 December 2020

Yellow fever - prevention in travellers.

1 reference

12 December 2020

Immune response to dengue virus and prospects for a vaccine

1 reference

12 December 2020

Vaccination with dengue virus-like particles induces humoral and cellular immune responses in mice

1 reference

12 December 2020

A prime-boost strategy using virus-like particles pseudotyped for HCV proteins triggers broadly neutralizing antibodies in macaques

1 reference

12 December 2020

West Nile virus: immunity and pathogenesis

1 reference

12 December 2020

Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2.

1 reference

12 December 2020

Production of Japanese encephalitis virus-like particles using the baculovirus-insect cell system

1 reference

12 December 2020

Induction of virus-neutralizing antibodies and T cell responses by dengue virus type 1 virus-like particles prepared from Pichia pastoris.

1 reference

12 December 2020

Cross-protective capacity of Japanese encephalitis (JE) vaccines against circulating heterologous JE virus genotypes

1 reference

12 December 2020

Hepatitis C VLPs delivered to dendritic cells by a TLR2 targeting lipopeptide results in enhanced antibody and cell-mediated responses

1 reference

12 December 2020

Chimeric hepatitis B virus/hepatitis C virus envelope proteins elicit broadly neutralizing antibodies and constitute a potential bivalent prophylactic vaccine

1 reference

12 December 2020

Virus-like particles displaying envelope domain III of dengue virus type 2 induce virus-specific antibody response in mice

1 reference

12 December 2020

Production of Japanese encephalitis virus-like particles in insect cells

1 reference

12 December 2020

Pichia pastoris-expressed dengue 2 envelope forms virus-like particles without pre-membrane protein and induces high titer neutralizing antibodies

1 reference

12 December 2020

Epidemiology of dengue: past, present and future prospects

1 reference

12 December 2020

Yellow fever vaccine: an effective vaccine for travelers

1 reference

12 December 2020

Vaccines in development against West Nile virus

1 reference

12 December 2020

A review of successful flavivirus vaccines and the problems with those flaviviruses for which vaccines are not yet available

1 reference

12 December 2020

Generation and characterization of a new mammalian cell line continuously expressing virus-like particles of Japanese encephalitis virus for a subunit vaccine candidate

1 reference

12 December 2020

Cloning and Expression of Recombinant Tick-Borne Encephalitis Virus-like Particles in Pichia pastoris

1 reference

12 December 2020

Tetravalent recombinant dengue virus-like particles as potential vaccine candidates: immunological properties

1 reference

12 December 2020

Glycoprotein E of the Japanese encephalitis virus forms virus-like particles and induces syncytia when expressed by a baculovirus

1 reference

12 December 2020

Tick-borne encephalitis: A review of epidemiology, clinical characteristics, and management

1 reference

12 December 2020

Generation and preclinical immunogenicity study of dengue type 2 virus-like particles derived from stably transfected mosquito cells

1 reference

12 December 2020

Pichia pastoris-expressed dengue 3 envelope-based virus-like particles elicit predominantly domain III-focused high titer neutralizing antibodies.

1 reference

12 December 2020

Hepatitis C Virus E1 and E2 Proteins Used as Separate Immunogens Induce Neutralizing Antibodies with Additive Properties

1 reference

12 December 2020

1 reference

12 December 2020

DNA-launched live-attenuated vaccines for biodefense applications

1 reference

12 December 2020

Low Protective Efficacy of the Current Japanese Encephalitis Vaccine against the Emerging Genotype 5 Japanese Encephalitis Virus

1 reference

12 December 2020

Characterization of a hepatitis C virus-like particle vaccine produced in a human hepatocyte-derived cell line

1 reference

12 December 2020

Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodies

1 reference

12 December 2020

Production of immunogenic West Nile virus-like particles using a herpes simplex virus 1 recombinant vector

1 reference

12 December 2020

Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus

1 reference

12 December 2020

Vaccine protection against Zika virus from Brazil

1 reference

12 December 2020

Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys

1 reference

12 December 2020

Zika: the origin and spread of a mosquito-borne virus

1 reference

12 December 2020

Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice

1 reference

12 December 2020

Recombinant Dengue Virus 4 Envelope Glycoprotein Virus-Like Particles Derived from Pichia pastoris are Capable of Eliciting Homotypic Domain III-Directed Neutralizing Antibodies.

1 reference

12 December 2020

Mapping and Role of the CD8+ T Cell Response During Primary Zika Virus Infection in Mice

1 reference

12 December 2020

Yellow Fever — Once Again on the Radar Screen in the Americas

1 reference

12 December 2020

Development of a Japanese encephalitis virus-like particle vaccine in silkworms using codon-optimised prM and envelope genes

1 reference

12 December 2020

Zika virus-like particle (VLP) based vaccine

1 reference

12 December 2020

Progress and Works in Progress: Update on Flavivirus Vaccine Development

1 reference

12 December 2020

Development of Virus like Particle Vaccine and Reporter Assay for Zika Virus

1 reference

12 December 2020

Virus-like particles that display Zika virus envelope protein domain III induce potent neutralizing immune responses in mice

1 reference

12 December 2020

Major findings and recent advances in virus-like particle (VLP)-based vaccines

1 reference

12 December 2020

An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design

1 reference

12 December 2020

An Overview of Yellow Fever Virus Disease

1 reference

12 December 2020

Safety and Immunogenicity of an Anti-Zika Virus DNA Vaccine - Preliminary Report.

1 reference

12 December 2020

Are we prepared for emerging flaviviruses in Europe? Challenges for vaccination

1 reference

12 December 2020

Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials

1 reference

12 December 2020

Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials

1 reference

12 December 2020

Cross-neutralisation of viruses of the tick-borne encephalitis complex following tick-borne encephalitis vaccination and/or infection

1 reference

12 December 2020

A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice

1 reference

12 December 2020

Powassan Virus—A New Reemerging Tick-Borne Disease

1 reference

12 December 2020

Pichia pastoris-Expressed Bivalent Virus-Like Particulate Vaccine Induces Domain III-Focused Bivalent Neutralizing Antibodies without Antibody-Dependent Enhancement in Vivo

1 reference

12 December 2020

Development of vaccines against Zika virus.

1 reference

12 December 2020

Existing and potential infection risk zones of yellow fever worldwide: a modelling analysis.

1 reference

12 December 2020

Immunological responses following administration of a genotype 1a/1b/2/3a quadrivalent HCV VLP vaccine.

1 reference

12 December 2020

Genotype I of Japanese Encephalitis Virus Virus-like Particles Elicit Sterilizing Immunity against Genotype I and III Viral Challenge in Swine.

1 reference

12 December 2020

Zika Virus Baculovirus-Expressed Virus-Like Particles Induce Neutralizing Antibodies in Mice.

1 reference

12 December 2020

Dengue envelope-based 'four-in-one' virus-like particles produced using Pichia pastoris induce enhancement-lacking, domain III-directed tetravalent neutralising antibodies in mice.

1 reference

12 December 2020

Current status of Zika vaccine development: Zika vaccines advance into clinical evaluation.

1 reference

12 December 2020

Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectors.

1 reference

12 December 2020

Zika Virus Vaccine: Progress and Challenges

1 reference

12 December 2020

Serostatus-dependent performance of the first licensed dengue vaccine: implications for travellers

1 reference

12 December 2020

Investigating Tick-borne Flaviviral-like Particles as a Delivery System for Gene Therapy

1 reference

12 December 2020

Immunogenicity and Protection After Vaccination With a Modified Vaccinia Virus Ankara-Vectored Yellow Fever Vaccine in the Hamster Model

1 reference

12 December 2020

Towards the risk of yellow fever transmission in Europe

1 reference

12 December 2020

Yellow fever outbreak in Brazil: the puzzle of rapid viral spread and challenges for immunisation

1 reference

12 December 2020

Recent Advances in Zika Virus Vaccines

1 reference

12 December 2020

An mRNA Vaccine Protects Mice against Multiple Tick-Transmitted Flavivirus Infections

1 reference

12 December 2020

Production and Biomedical Application of Flavivirus-like Particles

1 reference

12 December 2020

Pre-clinical evaluation of a quadrivalent HCV VLP vaccine in pigs following microneedle delivery

1 reference

12 December 2020

Identifiers

DOI

10.3390/VACCINES7040123

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31547131%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31547131%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

1 reference